Copyright Reports & Markets. All rights reserved.

Whole Exome Sequencing Market to 2027 - Global Analysis and Forecasts By Products & Service (Systems, Kits, Services); Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies); Applications (Diagnostics, Drug Discovery & Development, Personalized Medicine, Others) and Geography

Buy now

TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Global Whole Exome Sequencing Market – By Product & Service
      • 1.3.2 Global Whole Exome Sequencing Market – By Technology
      • 1.3.3 Global Whole Exome Sequencing Market – By Application
      • 1.3.4 Global Whole Exome Sequencing Market – By Geography

    2. Global Whole Exome Sequencing Market – Key Takeaways

      3. Research Methodology

      • 3.1 Coverage
      • 3.2 Secondary Research
      • 3.3 Primary Research

      4. Global Whole Exome Sequencing– Market Landscape

      • 4.1 Overview
      • 4.2 PEST Analysis
        • 4.2.1 North America – PEST Analysis
        • 4.2.2 Europe– PEST Analysis
        • 4.2.3 Asia Pacific– PEST Analysis
        • 4.2.4 Middle East and Africa – PEST Analysis
        • 4.2.5 South and Central America – PEST Analysis
      • 4.3 Expert Opinions

      5. Global Whole Exome Sequencing Market – Key Industry Dynamics

      • 5.1 Key Market Drivers
        • 5.1.1 Reduction in Time and Cost for Sequencing
        • 5.1.2 Rising Need of Molecular Diagnosis
        • 5.1.3 Increasing Application in Drug Discovery
      • 5.2 Key Market Restraints
        • 5.2.1 Ethical, Social and Legal Concerns For Whole Exome Sequencing
        • 5.2.2 Dearth of Highly Skilled Professionals
      • 5.3 Key Market Opportunity
        • 5.3.1 Development of Personalized Medicine
      • 5.4 Future Trend
        • 5.4.1 Diagnosing and Treating Cancer Using Whole Exome Sequencing
      • 5.5 Impact Analysis of Drivers and Restraints

      6. Whole Exome Sequencing Market – Global Analysis

      • 6.1 Global Whole Exome Sequencing Market Revenue Forecasts And Analysis
      • 6.2 Global Whole Exome Sequencing Market, By Geography - Forecasts And Analysis
      • 6.3 Performance Of Key Players
      • 6.4 Positioning Of Key Players

      7. Whole Exome Sequencing Market Analysis And Forecasts To 2027 – Product & Services

      • 7.1 Overview
      • 7.2 Global Whole Exome Sequencing Market Share by Product 2018 & 2027 (%)
      • 7.3 Systems Market
        • 7.3.1 Overview
        • 7.3.2 Systems Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4 Kits Market
        • 7.4.1 Overview
        • 7.4.2 Kits Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.5 Services Market
        • 7.5.1 Overview
        • 7.5.2 Services Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.5.3 Sequencing Services Market
          • 7.5.3.1 Overview
          • 7.5.3.2 Sequencing Services Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.5.4 Data Analysis (Bioinformatics) Services Market
          • 7.5.4.1 Overview
          • 7.5.4.2 Data Analysis (Bioinformatics) Services Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.5.5 Others Services Market
          • 7.5.5.1 Overview
          • 7.5.5.2 Others Services Market Revenue and Forecast to 2027 (US$ Mn)

        8. Global Whole Exome Sequencing Market Analysis to 2027 - Technology

        • 8.1 Overview
        • 8.2 Global Whole Exome Sequencing Market Share by Technology 2018 & 2027 (%)
        • 8.3 Sequencing by Synthesis
          • 8.3.1 Overview
          • 8.3.2 Sequencing by Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
        • 8.4 Ion Semiconductor Sequencing
          • 8.4.1 Overview
          • 8.4.2 Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
        • 8.5 Other Technologies
          • 8.5.1 Overview
          • 8.5.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)

        9. Whole Exome Sequencing Market Analysis And Forecasts To 2027 – Application

        • 9.1 Overview
        • 9.2 Global Whole Exome Sequencing Market Share by Application 2018 & 2027 (%)
        • 9.3 Diagnostics
          • 9.3.1 Overview
          • 9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.3.3 Cancer Diagnostics
            • 9.3.3.1 Overview
            • 9.3.3.2 Cancer Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.3.4 Monogenic (Mendelian) Disorders Diagnostics
            • 9.3.4.1 Overview
            • 9.3.4.2 Monogenic (Mendelian) Disorders Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.3.5 Monogenic Types of Diabetes Diagnostics
            • 9.3.5.1 Overview
            • 9.3.5.2 Monogenic Types of Diabetes Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.3.6 HIV Diagnostics
            • 9.3.6.1 Overview
            • 9.3.6.2 HIV Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
          • 9.3.7 Others Diagnostics
            • 9.3.7.1 Overview
            • 9.3.7.2 Others Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.4 Drug Discovery & Development
          • 9.4.1 Overview
          • 9.4.2 Drug Discovery & Development Market Revenue and Forecast To 2027 (US$ Mn)
        • 9.5 Personalized Medicine
          • 9.5.1 Overview
          • 9.5.2 Personalized Medicine Market Revenue and Forecasts To 2027 (US$ Mn)
        • 9.6 Other Application
          • 9.6.1 Overview
          • 9.6.2 Other Application Market Revenue and Forecasts To 2027 (US$ Mn)

        10. Whole Exome Sequencing Market Revenue And Forecasts To 2027 – Regional Analysis

        • 10.1 North America Whole Sequencing Market
          • 10.1.1 Overview
          • 10.1.2 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.1.3 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
            • 10.1.3.1 North America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
          • 10.1.4 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 10.1.5 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
            • 10.1.5.1 North America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
          • 10.1.6 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
          • 10.1.7 US Whole Exome Sequencing Market
            • 10.1.7.1 US Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.1.7.2 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
            • 10.1.7.2.1 US Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
            • 10.1.7.3 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
            • 10.1.7.4 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
            • 10.1.7.4.1 US Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
            • 10.1.8 Canada Whole Exome Sequencing Market
              • 10.1.8.1 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
              • 10.1.8.2 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
              • 10.1.8.2.1 Canada Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
              • 10.1.8.3 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
              • 10.1.8.4 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
              • 10.1.8.4.1 Canada Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
              • 10.1.9 Mexico Whole Exome Sequencing Market
                • 10.1.9.1 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                • 10.1.9.2 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                • 10.1.9.2.1 Mexico Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                • 10.1.9.3 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                • 10.1.9.4 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                • 10.1.9.4.1 Mexico Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                • 10.2 Europe Whole Exome Sequencing Market
                  • 10.2.1 Overview
                  • 10.2.2 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                  • 10.2.3 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                    • 10.2.3.1 Europe Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                  • 10.2.4 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                  • 10.2.5 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                    • 10.2.5.1 Europe Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                  • 10.2.6 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
                  • 10.2.7 UK Whole Exome Sequencing Market
                    • 10.2.7.1 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                    • 10.2.7.2 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                    • 10.2.7.2.1 UK Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                    • 10.2.7.3 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                    • 10.2.7.4 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                    • 10.2.7.4.1 UK Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                    • 10.2.8 Germany Whole Exome Sequencing Market
                      • 10.2.8.1 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                      • 10.2.8.2 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                      • 10.2.8.2.1 Germany Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                      • 10.2.8.3 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                      • 10.2.8.4 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                      • 10.2.8.4.1 Germany Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                      • 10.2.9 France Whole Exome Sequencing Market
                        • 10.2.9.1 France Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                        • 10.2.9.2 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                        • 10.2.9.2.1 France Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                        • 10.2.9.3 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                        • 10.2.9.4 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                        • 10.2.9.4.1 France Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                        • 10.2.10 Spain Whole Exome Sequencing Market
                          • 10.2.10.1 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                          • 10.2.10.2 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                          • 10.2.10.2.1 Spain Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                          • 10.2.10.3 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                          • 10.2.10.4 Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                          • 10.2.10.4.1 Spain Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                          • 10.2.11 Italy Whole Exome Sequencing Market
                            • 10.2.11.1 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                            • 10.2.11.2 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                            • 10.2.11.2.1 Italy Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                            • 10.2.11.3 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                            • 10.2.11.4 Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                            • 10.2.11.4.1 Italy Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                            • 10.3 Asia Pacific Whole Exome Sequencing Market
                              • 10.3.1 Overview
                              • 10.3.2 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                              • 10.3.3 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                • 10.3.3.1 Asia Pacific Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                              • 10.3.4 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                              • 10.3.5 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                • 10.3.5.1 Asia Pacific Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                              • 10.3.6 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
                              • 10.3.7 China Whole Exome Sequencing Market
                                • 10.3.7.1 China Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                • 10.3.7.2 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                • 10.3.7.2.1 China Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                • 10.3.7.3 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                • 10.3.7.4 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                • 10.3.7.4.1 China Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                • 10.3.8 Japan Whole Exome Sequencing Market
                                  • 10.3.8.1 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                  • 10.3.8.2 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                  • 10.3.8.2.1 Japan Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                  • 10.3.8.3 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                  • 10.3.8.4 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                  • 10.3.8.4.1 Japan Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                  • 10.3.9 India Whole Exome Sequencing Market
                                    • 10.3.9.1 India Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                    • 10.3.9.2 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                    • 10.3.9.2.1 India Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                    • 10.3.9.3 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                    • 10.3.9.4 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                    • 10.3.9.4.1 India Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                    • 10.3.10 Australia Whole Exome Sequencing Market
                                      • 10.3.10.1 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                      • 10.3.10.2 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                      • 10.3.10.2.1 Australia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                      • 10.3.10.3 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                      • 10.3.10.4 Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                      • 10.3.10.4.1 Australia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                      • 10.3.11 South Korea Whole Exome Sequencing Market
                                        • 10.3.11.1 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                        • 10.3.11.2 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                        • 10.3.11.2.1 South Korea Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                        • 10.3.11.3 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                        • 10.3.11.4 South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                        • 10.3.11.4.1 South Korea Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                        • 10.4 Middle East & Africa Whole Exome Sequencing Market
                                          • 10.4.1 Overview
                                          • 10.4.2 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                          • 10.4.3 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                            • 10.4.3.1 Middle East & Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                          • 10.4.4 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                          • 10.4.5 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                            • 10.4.5.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                          • 10.4.6 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
                                          • 10.4.7 UAE Whole Exome Sequencing Market
                                            • 10.4.7.1 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                            • 10.4.7.2 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                            • 10.4.7.2.1 UAE Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                            • 10.4.7.3 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                            • 10.4.7.4 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                            • 10.4.7.4.1 UAE Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                            • 10.4.8 Saudi Arabia Whole Exome Sequencing Market
                                              • 10.4.8.1 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                              • 10.4.8.2 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                              • 10.4.8.2.1 Saudi Arabia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                              • 10.4.8.3 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                              • 10.4.8.4 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                              • 10.4.8.4.1 Saudi Arabia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                              • 10.4.9 South Africa Whole Exome Sequencing Market
                                                • 10.4.9.1 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                                • 10.4.9.2 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                                • 10.4.9.2.1 South Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                • 10.4.9.3 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                                • 10.4.9.4 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                                • 10.4.9.4.1 South Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                • 10.5 South and Central America Whole Exome Sequencing Market
                                                  • 10.5.1 Overview
                                                  • 10.5.2 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                                  • 10.5.3 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                                    • 10.5.3.1 South and Central America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                  • 10.5.4 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                                  • 10.5.5 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                                    • 10.5.5.1 South and Central America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                  • 10.5.6 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
                                                  • 10.5.7 Brazil Whole Exome Sequencing Market
                                                    • 10.5.7.1 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                                    • 10.5.7.2 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                                    • 10.5.7.2.1 Brazil Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                    • 10.5.7.3 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                                    • 10.5.7.4 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                                    • 10.5.7.4.1 Brazil Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                    • 10.5.8 Argentina Whole Exome Sequencing Market
                                                      • 10.5.8.1 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
                                                      • 10.5.8.2 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
                                                      • 10.5.8.2.1 Argentina Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
                                                      • 10.5.8.3 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
                                                      • 10.5.8.4 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
                                                      • 10.5.8.4.1 Argentina Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)

                                                      11. Whole Exome Sequencing Market –Industry Landscape

                                                      • 11.1 Overview
                                                      • 11.2 Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
                                                      • 11.3 Organic Developments
                                                        • 11.3.1 Overview
                                                        • 11.3.2 Organic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
                                                      • 11.4 Inorganic Developments
                                                        • 11.4.1 Overview
                                                        • 11.4.2 Inorganic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019

                                                      12. Whole Exome Sequencing Market–Key Company Profiles

                                                      • 12.1 Stratos Genomics
                                                        • 12.1.1 Key Facts
                                                        • 12.1.2 Business Description
                                                        • 12.1.3 Financial Overview
                                                        • 12.1.4 Product Portfolio
                                                        • 12.1.5 SWOT Analysis
                                                        • 12.1.6 Key Developments
                                                      • 12.2 Bio-Rad Laboratories, Inc.
                                                        • 12.2.1 Key Facts
                                                        • 12.2.2 Business Description
                                                        • 12.2.3 Financial Overview
                                                        • 12.2.4 Product Portfolio
                                                        • 12.2.5 SWOT Analysis
                                                        • 12.2.6 Key Developments
                                                      • 12.3 Eurofins Scientific
                                                        • 12.3.1 Key Facts
                                                        • 12.3.2 Business Description
                                                        • 12.3.3 Product Portfolio
                                                        • 12.3.4 Financial Overview
                                                        • 12.3.5 SWOT Analysis
                                                        • 12.3.6 Key Developments
                                                      • 12.4 F. Hoffmann-La Roche Ltd.
                                                        • 12.4.1 Key Facts
                                                        • 12.4.2 Business Description
                                                        • 12.4.3 Financial Overview
                                                        • 12.4.4 Product Portfolio
                                                        • 12.4.5 SWOT Analysis
                                                        • 12.4.6 Key Developments
                                                      • 12.5 Pacific Bioscience of California, Inc.
                                                        • 12.5.1 Key Facts
                                                        • 12.5.2 Business Description
                                                        • 12.5.3 Financial Overview
                                                        • 12.5.4 Product Portfolio
                                                        • 12.5.5 SWOT Analysis
                                                        • 12.5.6 Key Developments
                                                      • 12.6 GENEWIZ
                                                        • 12.6.1 Key Facts
                                                        • 12.6.2 Business Description
                                                        • 12.6.3 Financial Overview
                                                        • 12.6.4 Product Portfolio
                                                        • 12.6.5 SWOT Analysis
                                                        • 12.6.6 Key Developments
                                                      • 12.7 Psomagen, Inc.
                                                        • 12.7.1 Key Facts
                                                        • 12.7.2 Business Description
                                                        • 12.7.3 Financial Overview
                                                        • 12.7.4 Product Portfolio
                                                        • 12.7.5 SWOT Analysis
                                                        • 12.7.6 Key Developments
                                                      • 12.8 Thermo Fisher Scientific, Inc.
                                                        • 12.8.1 Key Facts
                                                        • 12.8.2 Business Description
                                                        • 12.8.3 Financial Overview
                                                        • 12.8.4 Product Portfolio
                                                        • 12.8.5 SWOT Analysis
                                                        • 12.8.6 Key Developments
                                                      • 12.9 Illumina, Inc.
                                                        • 12.9.1 Key Facts
                                                        • 12.9.2 Business Description
                                                        • 12.9.3 Financial Overview
                                                        • 12.9.4 Product Portfolio
                                                        • 12.9.5 SWOT Analysis
                                                        • 12.9.6 Key Developments
                                                      • 12.10 Centogene
                                                        • 12.10.1 Key Facts
                                                        • 12.10.2 Business Description
                                                        • 12.10.3 Financial Overview
                                                        • 12.10.4 Product Portfolio
                                                        • 12.10.5 SWOT Analysis
                                                        • 12.10.6 Key Developments

                                                      13. Appendix

                                                      • 13.1 About The Insight Partners
                                                      • 13.2 Glossary of Terms

      The global whole exome sequencing market is expected to reach US$ 3,812.0 Mn in 2027 from US$ 755.68 Mn in 2018. The market is estimated to grow with a CAGR of 19.8% from 2019-2027.
      The market is driven by the factors such as, reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome sequencing market. However, ethical, social and legal concerns for whole exome sequencing and dearth of highly skilled professionals may restrict the growth of whole exome sequencing market.
      The next-generation sequencing has enabled higher results of the analysis for genotypic and phenotypic relations among the human populations, helping in the development of genetics information for the drug development. In various human diseases are caused or are influenced by the genetic factors which provide important information about the diseases and thus help in the discovery of a novel drug.
      As the whole sequencing techniques reduced time and cost for the analyzing genetic, it also offers a reduction of time spent in the trial and error for the drug formulation. The technique offers precise ability to measure the genetic variation among humans and their biological samples. Pharmaceutical companies influence this technology to fine-tune the germline genome to stabilize which, in return, enable then to buy an insurance policy during the presentation of initial findings to the FDA for the early stage approvals.
      The significant reduction in the prices and rising technology is leading to the shift towards emphasizing drug development through whole-exome sequencing. Thus, owing to these factors, it is expected that the market is likely to propel expressively during the forecast period.
      Some of the major primary and secondary sources included in the report for the whole exome sequencing market are World Health Organization, National Institute of Health and Medical Research, Centers for Disease Control and Prevention, The New England Journal of Medicine, among the others.

      Buy now